-Bloomberg
Cantor Fitzgerald Cuts Price Target On This Cannabis MSO, But Touts Its Operations As ‘One Of Best-In-Class’
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) reported its financial results on Wednesday for the second quarter of fiscal 2022, revealing a 4% year-ove